Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fertilization in Vitro | 6 | 2024 | 146 | 1.720 |
Why?
|
| Embryo Implantation | 3 | 2024 | 234 | 1.540 |
Why?
|
| Fertility Preservation | 4 | 2021 | 54 | 1.390 |
Why?
|
| Embryo Transfer | 4 | 2023 | 57 | 1.090 |
Why?
|
| Infertility, Female | 4 | 2024 | 145 | 0.970 |
Why?
|
| Endometrium | 2 | 2024 | 282 | 0.910 |
Why?
|
| Reproductive Techniques, Assisted | 4 | 2021 | 70 | 0.910 |
Why?
|
| Cryopreservation | 3 | 2021 | 73 | 0.900 |
Why?
|
| Observational Studies as Topic | 1 | 2024 | 87 | 0.890 |
Why?
|
| Ovulation Induction | 1 | 2021 | 42 | 0.720 |
Why?
|
| Preimplantation Diagnosis | 1 | 2020 | 22 | 0.690 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 150 | 0.670 |
Why?
|
| Pregnancy, Twin | 1 | 2021 | 177 | 0.670 |
Why?
|
| Embryonic Development | 1 | 2020 | 210 | 0.620 |
Why?
|
| Oocytes | 1 | 2020 | 284 | 0.620 |
Why?
|
| Ovary | 2 | 2021 | 380 | 0.600 |
Why?
|
| Anemia, Aplastic | 1 | 2018 | 60 | 0.580 |
Why?
|
| Ovariectomy | 1 | 2018 | 182 | 0.580 |
Why?
|
| Pregnancy | 15 | 2024 | 7167 | 0.570 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 534 | 0.560 |
Why?
|
| Peritoneum | 1 | 2017 | 36 | 0.550 |
Why?
|
| Therapies, Investigational | 1 | 2016 | 12 | 0.540 |
Why?
|
| Uterus | 3 | 2017 | 571 | 0.520 |
Why?
|
| Chemoradiotherapy | 1 | 2017 | 104 | 0.520 |
Why?
|
| Infertility | 1 | 2017 | 76 | 0.510 |
Why?
|
| Rectal Neoplasms | 1 | 2017 | 79 | 0.500 |
Why?
|
| Prenatal Diagnosis | 1 | 2020 | 597 | 0.500 |
Why?
|
| Fertility | 1 | 2017 | 257 | 0.470 |
Why?
|
| Genetic Testing | 1 | 2020 | 1004 | 0.440 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 422 | 0.400 |
Why?
|
| Laparoscopy | 1 | 2017 | 489 | 0.370 |
Why?
|
| Placenta Previa | 2 | 2021 | 65 | 0.340 |
Why?
|
| Female | 24 | 2024 | 66301 | 0.320 |
Why?
|
| Placenta Accreta | 2 | 2021 | 155 | 0.300 |
Why?
|
| Pregnancy Outcome | 3 | 2020 | 589 | 0.280 |
Why?
|
| Neoplasms | 2 | 2018 | 2801 | 0.260 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2022 | 449 | 0.260 |
Why?
|
| Pregnancy Rate | 2 | 2023 | 31 | 0.260 |
Why?
|
| Humans | 23 | 2024 | 124394 | 0.230 |
Why?
|
| Review Literature as Topic | 1 | 2024 | 45 | 0.220 |
Why?
|
| Retrospective Studies | 7 | 2023 | 16233 | 0.210 |
Why?
|
| Treatment Failure | 1 | 2024 | 342 | 0.210 |
Why?
|
| Fibromyalgia | 1 | 2022 | 17 | 0.210 |
Why?
|
| Meta-Analysis as Topic | 1 | 2023 | 155 | 0.200 |
Why?
|
| Adult | 9 | 2021 | 29396 | 0.200 |
Why?
|
| Abortion, Spontaneous | 1 | 2022 | 79 | 0.190 |
Why?
|
| Fertilization | 1 | 2021 | 42 | 0.180 |
Why?
|
| Superovulation | 1 | 2020 | 11 | 0.180 |
Why?
|
| Embryo Culture Techniques | 1 | 2020 | 25 | 0.180 |
Why?
|
| DNA Fragmentation | 1 | 2020 | 54 | 0.180 |
Why?
|
| Blastocyst | 1 | 2020 | 74 | 0.180 |
Why?
|
| Maternal Age | 2 | 2017 | 132 | 0.170 |
Why?
|
| Research Design | 1 | 2024 | 687 | 0.170 |
Why?
|
| Pregnancy Trimester, First | 1 | 2020 | 114 | 0.170 |
Why?
|
| Maternal Mortality | 1 | 2020 | 80 | 0.160 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 261 | 0.160 |
Why?
|
| Aneuploidy | 1 | 2020 | 154 | 0.160 |
Why?
|
| 46, XX Disorders of Sex Development | 1 | 2017 | 22 | 0.140 |
Why?
|
| Cancer Care Facilities | 1 | 2016 | 31 | 0.140 |
Why?
|
| Mullerian Ducts | 1 | 2017 | 33 | 0.140 |
Why?
|
| Cesarean Section | 1 | 2020 | 387 | 0.130 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 477 | 0.130 |
Why?
|
| Hormone Antagonists | 1 | 2016 | 60 | 0.130 |
Why?
|
| Contraceptive Agents, Female | 1 | 2016 | 29 | 0.130 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2016 | 80 | 0.130 |
Why?
|
| Choice Behavior | 1 | 2016 | 131 | 0.120 |
Why?
|
| Aromatase Inhibitors | 1 | 2016 | 77 | 0.120 |
Why?
|
| Leiomyoma | 1 | 2016 | 83 | 0.120 |
Why?
|
| Influenza, Human | 1 | 2021 | 657 | 0.120 |
Why?
|
| Uterine Neoplasms | 1 | 2016 | 107 | 0.120 |
Why?
|
| Plant Extracts | 1 | 2016 | 121 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 358 | 0.120 |
Why?
|
| Organ Transplantation | 1 | 2017 | 164 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 374 | 0.120 |
Why?
|
| DNA Methylation | 1 | 2020 | 1002 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 720 | 0.110 |
Why?
|
| Congenital Abnormalities | 1 | 2017 | 254 | 0.110 |
Why?
|
| Fallopian Tubes | 1 | 2014 | 71 | 0.110 |
Why?
|
| Androgens | 1 | 2016 | 275 | 0.110 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2014 | 74 | 0.110 |
Why?
|
| Germ Cells | 1 | 2014 | 195 | 0.110 |
Why?
|
| Infant, Newborn | 3 | 2021 | 8184 | 0.110 |
Why?
|
| Premature Birth | 1 | 2017 | 384 | 0.100 |
Why?
|
| Patient Selection | 1 | 2016 | 688 | 0.100 |
Why?
|
| Referral and Consultation | 1 | 2016 | 539 | 0.100 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 1085 | 0.100 |
Why?
|
| Young Adult | 4 | 2020 | 8979 | 0.090 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 605 | 0.090 |
Why?
|
| Tissue Survival | 2 | 2021 | 8 | 0.080 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 1817 | 0.060 |
Why?
|
| Middle Aged | 4 | 2020 | 26459 | 0.060 |
Why?
|
| United States | 2 | 2017 | 10773 | 0.060 |
Why?
|
| Animals | 3 | 2021 | 34139 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2017 | 12287 | 0.060 |
Why?
|
| Pandemics | 2 | 2022 | 1102 | 0.050 |
Why?
|
| Mice | 1 | 2020 | 17725 | 0.050 |
Why?
|
| Morphine Derivatives | 1 | 2022 | 6 | 0.050 |
Why?
|
| Live Birth | 1 | 2022 | 54 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2022 | 4734 | 0.050 |
Why?
|
| Fibrin | 1 | 2022 | 66 | 0.050 |
Why?
|
| Adolescent | 2 | 2016 | 19358 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 3427 | 0.050 |
Why?
|
| Intention | 1 | 2021 | 92 | 0.050 |
Why?
|
| Hysterectomy | 1 | 2022 | 192 | 0.050 |
Why?
|
| Sheep | 1 | 2021 | 212 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2021 | 298 | 0.040 |
Why?
|
| Iran | 1 | 2020 | 59 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 257 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 409 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 305 | 0.040 |
Why?
|
| Incidence | 2 | 2017 | 3086 | 0.040 |
Why?
|
| Placenta | 1 | 2022 | 506 | 0.040 |
Why?
|
| Child | 1 | 2018 | 24526 | 0.040 |
Why?
|
| Reproductive Health Services | 1 | 2016 | 17 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2020 | 1246 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2017 | 168 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 286 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 1417 | 0.030 |
Why?
|
| Estrogen Receptor Antagonists | 1 | 2016 | 4 | 0.030 |
Why?
|
| Estrenes | 1 | 2016 | 21 | 0.030 |
Why?
|
| Norpregnadienes | 1 | 2016 | 7 | 0.030 |
Why?
|
| Intrauterine Devices, Medicated | 1 | 2016 | 6 | 0.030 |
Why?
|
| Vaccination | 1 | 2021 | 953 | 0.030 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2016 | 14 | 0.030 |
Why?
|
| Tea | 1 | 2016 | 15 | 0.030 |
Why?
|
| Genital Neoplasms, Female | 1 | 2016 | 46 | 0.030 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2016 | 16 | 0.030 |
Why?
|
| Levonorgestrel | 1 | 2016 | 20 | 0.030 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2016 | 19 | 0.030 |
Why?
|
| Uterine Myomectomy | 1 | 2016 | 10 | 0.030 |
Why?
|
| Mifepristone | 1 | 2016 | 135 | 0.030 |
Why?
|
| Oximes | 1 | 2016 | 50 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2016 | 111 | 0.030 |
Why?
|
| Curcumin | 1 | 2016 | 41 | 0.030 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2016 | 60 | 0.030 |
Why?
|
| Vitamins | 1 | 2016 | 107 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 1414 | 0.030 |
Why?
|
| Risk Factors | 2 | 2020 | 10149 | 0.030 |
Why?
|
| Graft Survival | 1 | 2017 | 528 | 0.030 |
Why?
|
| HELLP Syndrome | 1 | 2014 | 18 | 0.030 |
Why?
|
| Vitamin D | 1 | 2016 | 159 | 0.030 |
Why?
|
| Fetal Monitoring | 1 | 2014 | 56 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2016 | 326 | 0.030 |
Why?
|
| Estradiol | 1 | 2016 | 534 | 0.030 |
Why?
|
| Hematologic Neoplasms | 1 | 2016 | 286 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 628 | 0.020 |
Why?
|
| Pre-Eclampsia | 1 | 2014 | 221 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2016 | 879 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2017 | 815 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 397 | 0.020 |
Why?
|
| Infant | 1 | 2022 | 12479 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 2896 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 2508 | 0.010 |
Why?
|